Publications
- Effectiveness of natalizumab extended interval dosing in multiple sclerosis patients2020 | Second Faculty of Medicine
- Myxovirus resistance protein A in interferon-β therapy in patients with multiple sclerosis and treatment effectiveness monitoring algorithm2016 | First Faculty of Medicine, Second Faculty of Medicine
- Clinical experience with alemtuzuma2016 | Second Faculty of Medicine
- Neutralising antibodies and Myxovirus resistance protein A as a marker of biological response to interferon β2014 | Second Faculty of Medicine
- Interpretation of neutralizing antibodies and myxovirus resitance protein A testing in patients with multiple sclerosis treated with interferon beta2014 | Second Faculty of Medicine
- Interferon-β biological activity; monitoring of the treatment effect in multiple sclerosis patients in the Czcech republic2013 | Second Faculty of Medicine
- Monitoring of the Biological Effect of Interferon Beta in the Treatment of Multiple Sclerosis2013 | Second Faculty of Medicine
- Monitoring of interferon beta bioactivity in the multiple sclerosis2011 | Second Faculty of Medicine
- Does initial high efficacy therapy in multiple sclerosis surpass escalation treatment strategy? A comparison of patients with relapsing-remitting multiple sclerosis in the Czech and Swedish national multiple sclerosis registries2023 | First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen
- Is breastfeeding in MS harmful or not? An answer from real-world Czech data2023 | First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen
Loading network view...